Invesco Pharmaceuticals ETF (PJP) Holdings history

Fund Profile

Current holdings

Data for period

31 Oct 24

(Last reporting period)

Total assets

$332.94 mm

Liabilities

$52.17 mm

Net assets

$280.77 mm

Number of holdings

29.00

Holding trends

Total assets and liabilities

Assets

Liabilities

Total number of holdings

Holdings history data

$Dollar values in millions. Negative values are Short positions. "0" is less than $100,000.

Filter holdings

All historic holdings

Current

Data to display

$Value

#Units

%Holdings

Shade data

Download data

Holding	Jan 20	Apr 20	Jul 20	Oct 20	Jan 21	Apr 21	Jul 21	Oct 21	Jan 22	Apr 22	Jul 22	Oct 22	Jan 23	Apr 23	Jul 23	Oct 23	Jan 24	Apr 24	Jul 24	Oct 24
Abbott Laboratories
AbbVie Inc.
Alexion Pharmaceuticals, Inc.
Allergan PLC
Amgen Inc.
Amneal Pharmaceuticals, Inc.
Amphastar Pharmaceuticals, Inc.
ANI Pharmaceuticals, Inc.
Bausch Health Cos. Inc.
Biogen Inc.
Bristol-Myers Squibb Co.
Corcept Therapeutics Inc.
Eagle Pharmaceuticals, Inc.
Eli Lilly and Co.
Emergent BioSolutions Inc.
Enanta Pharmaceuticals, Inc.
Endo International PLC
Five Prime Therapeutics, Inc.
Geron Corp.
Gilead Sciences, Inc.
Horizon Therapeutics PLC
Innoviva, Inc.
Invesco Government & Agency Portfolio
Invesco Liquid Assets Portfolio
Invesco Premier U.S. Government Money Portfolio
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
Invesco Private Government Fund Invesco Private Government Fund
INVESCO PRIVATE GOVERNMENT FUND INVESCO PRIVATE GOVERNMENT FUND
INVESCO PRIVATE GOVERNMENT FUND INVESCO PRIVATE GOVERNMENT FUND
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
Invesco Private Prime Fund Invesco Private Prime Fund
INVESCO PRIVATE PRIME FUND INVESCO PRIVATE PRIME FUND
INVESCO PRIVATE PRIME FUND INVESCO PRIVATE PRIME FUND
Jazz Pharmaceuticals PLC
Johnson & Johnson
Ligand Pharmaceuticals Inc.
Merck & Co., Inc.
Mylan N.V.
OmniAb Operations, Inc.
Pacira BioSciences, Inc.
Perrigo Co. PLC
Pfizer Inc.
Prestige Consumer Healthcare Inc.
Regeneron Pharmaceuticals, Inc.
Retrophin, Inc.
Supernus Pharmaceuticals, Inc.
Taro Pharmaceutical Industries Ltd.
Travere Therapeutics, Inc.
United Therapeutics Corp.
Vanda Pharmaceuticals, Inc.
Viatris Inc.